Myelodysplastic syndrome epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States.[1] Myelodysplastic syndrome commonly affects individuals older than 50 years of age.[2] Males are more commonly affected with myelodysplastic syndrome than females.[1] Myelodysplastic syndrome usually affects individuals of the Caucasian race.[1]
Epidemiology and Demographics
Incidence
The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States. MDS are diagnosed in slightly more than 10,000 people in the United States yearly.[1]
Age
Myelodysplastic syndrome commonly affects individuals older than 50 years of age.[2]
Gender
Males are more commonly affected with myelodysplastic syndrome than females.[1]
Race
Myelodysplastic syndrome usually affects individuals of the Caucasian race.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Incidence and mortality of myelodysplastic syndromes. National Cancer Institute 2015. http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq#link/_291_toc. Accessed on December 3, 2015
- ↑ 2.0 2.1 Natelson, Ethan A.; Pyatt, David (2013). “Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog”. Advances in Hematology. 2013: 1–11. doi:10.1155/2013/309637. ISSN 1687-9104.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH